NEW YORK (360Dx) – With at least a moderate level of certainty, harm outweighs the benefits of screening for ovarian cancer in asymptomatic women who are not at high risk, according to the US Preventive Services Task Force, a panel of experts that makes recommendations on clinical preventive services to primary care clinicians.

In a draft recommendation statement requesting public comment, the USPSTF said it has found "adequate evidence" that harm includes false-positive screening results that can lead to surgical interventions in women who do not have cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.